SynthesisEuropean journal of pediatrics2025
Reference ranges of blood glucose values in healthy term neonates in their first days of life: a systematic review and meta-analysis.
Synthesis in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neonatal hypoglycaemia is the most common metabolic disorder in the first days of life. Pathological hypoglycaemia, characterized by persistent or recurrent low glucose levels, can lead to brain injury, resulting in long-term adverse neurodevelopmental outcomes. It can be challenging to differentiate between physiological and pathological hypoglycaemia. This systematic review and meta-analysis aims to define time-stratified reference blood glucose values in healthy term neonates within the first 72 h of life. We searched PubMed, EMBASE and Web of Science to identify original studies reporting glucose values within 72 h post-delivery in healthy term neonates. Glucose patterns were analyzed by random-effect models, and a normalcy curve was generated by meta-regression. Thirty-nine studies (8538 neonates) were included. Random-effects forest plots revealed dynamic glucose trends. The meta-regression analysis generated a normalcy curve that revealed a rapid decrease in glucose levels to a median of 3.1 mmol/L within 2 h, followed by fluctuations around 3.2 mmol/L for up to 12 h, and stabilized glucose levels at 3.6 mmol/L between 36 and 72 h. The 10th percentiles are 2.1 mmol/L, 2.3 mmol/L, and 2.6 mmol/L at 0-2, 12, and 24 h, respectively.
conclusionWe observed a time-dependent change in neonatal glucose in the first 72 h after birth. The nadir was reached after 2 h, and glucose values gradually increased thereafter. A dynamic interpretation based on percentiles, with the 10th percentile as the lower limit of normal, may better capture variability in neonatal glucose regulation and allow for more personalized glucose management. WHAT IS KNOWN: • Neonates experience a transient, physiological drop in glucose after birth. • Defining cut-offs is challenging due to limited data on normal glucose transitions and the difficulty of distinguishing physiological from pathological hypoglycaemia. WHAT IS NEW: • We present a normalcy curve of blood glucose levels in the first 72 h of life of healthy term neonates with the 10th percentile as lower limit of normal. • We suggest that a personalized approach to glucose monitoring, with time-specific dynamic interpretation, could optimize neonatal glucose monitoring.
Indexed as
Identifiers
41398481What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.